330 related articles for article (PubMed ID: 22709682)
21. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
[TBL] [Abstract][Full Text] [Related]
22. Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.
Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Macas A; Sakalauskas R
Medicina (Kaunas); 2010; 46(7):490-5. PubMed ID: 20966623
[TBL] [Abstract][Full Text] [Related]
23. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
[TBL] [Abstract][Full Text] [Related]
24. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
[TBL] [Abstract][Full Text] [Related]
25. The clinical implications of ABO blood groups in Pseudomonas aeruginosa sepsis in children.
Kuo KC; Kuo HC; Huang LT; Lin CS; Yang SN
J Microbiol Immunol Infect; 2013 Apr; 46(2):109-14. PubMed ID: 22464692
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia.
Su TY; Ye JJ; Hsu PC; Wu HF; Chia JH; Lee MH
J Microbiol Immunol Infect; 2015 Apr; 48(2):175-82. PubMed ID: 24064286
[TBL] [Abstract][Full Text] [Related]
27. P. aeruginosa bloodstream infections among hematological patients: an old or new question?
Cattaneo C; Antoniazzi F; Casari S; Ravizzola G; Gelmi M; Pagani C; D'Adda M; Morello E; Re A; Borlenghi E; Manca N; Rossi G
Ann Hematol; 2012 Aug; 91(8):1299-304. PubMed ID: 22349723
[TBL] [Abstract][Full Text] [Related]
28. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
29. Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia.
Scheetz MH; Bolon MK; Scarsi KK; Fotis MA; Postelnick MJ
J Infect; 2006 Feb; 52(2):105-10. PubMed ID: 15904961
[TBL] [Abstract][Full Text] [Related]
30. Severe pseudomonal infections.
Mutlu GM; Wunderink RG
Curr Opin Crit Care; 2006 Oct; 12(5):458-63. PubMed ID: 16943726
[TBL] [Abstract][Full Text] [Related]
31. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.
Tam VH; Chang KT; Schilling AN; LaRocco MT; Genty LO; Garey KW
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):279-85. PubMed ID: 19135330
[TBL] [Abstract][Full Text] [Related]
32. [Pseudomonas aeruginosa bacteremia: clinical and epidemiological patterns and treatment].
Gómez J; Alcántara M; Simarro E; Martínez B; Ruiz J; Guerra B; Gómez Vargas J; Valdés M
Rev Esp Quimioter; 2002 Dec; 15(4):360-5. PubMed ID: 12587042
[TBL] [Abstract][Full Text] [Related]
33. Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.
Suárez C; Peña C; Gavaldà L; Tubau F; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e73-8. PubMed ID: 20223693
[TBL] [Abstract][Full Text] [Related]
34. [Prevention and antibiotic treatment of Pseudomonas aeruginosa septicemia].
Deng GH
Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):599-601, 637. PubMed ID: 8313182
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT
Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105
[TBL] [Abstract][Full Text] [Related]
36. Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism.
Ho SA; Lee TW; Denton M; Conway SP; Brownlee KG
J Cyst Fibros; 2009 Jan; 8(1):43-6. PubMed ID: 18829398
[TBL] [Abstract][Full Text] [Related]
37. The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit.
Armour AD; Shankowsky HA; Swanson T; Lee J; Tredget EE
J Trauma; 2007 Jul; 63(1):164-71. PubMed ID: 17622885
[TBL] [Abstract][Full Text] [Related]
38. Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum.
Traugott KA; Echevarria K; Maxwell P; Green K; Lewis JS
Pharmacotherapy; 2011 Jun; 31(6):598-608. PubMed ID: 21923444
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran.
Ranjbar R; Owlia P; Saderi H; Mansouri S; Jonaidi-Jafari N; Izadi M; Farshad S; Arjomandzadegan M
Acta Med Iran; 2011; 49(10):675-9. PubMed ID: 22071644
[TBL] [Abstract][Full Text] [Related]
40. [Gastrointestinal carriage of Pseudomonas aeruginosa in children residing in chronic care institutes in Jerusalem: high prevalence and high rates of antibiotic resistance].
Megged O; Schlesinger Y; Attias D; Rudensky B
Harefuah; 2009 Nov; 148(11):766-8, 793. PubMed ID: 20027979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
